We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Diagnostics

Image: Urine test for bladder cancer could replace 1000s of invasive cystoscopies each year (Photo courtesy of Pexels)

Urine Test for Bladder Cancer Could Reduce Need for Invasive Cystoscopies

Researchers at the University of Birmingham (Birmingham, UK) have developed a new urine test for bladder cancer that could reduce the need for invasive and time-consuming diagnostic procedures. More...
26 Apr 2022
Image: Rapid virus test delivers results as accurate as lab tests within 30 minutes (Photo courtesy of University of Texas at Dallas)

Rapid Virus Test Delivers Lab Quality Results within 30 Minutes

Researchers have developed a rapid test for viruses that can deliver results as accurate as lab tests within 30 minutes. The technology can be applied to viruses that cause respiratory syncytial virus, influenza and COVID-19. More...
26 Apr 2022
DIASOURCE (A Biovendor Company)
Image: Actiphage is a promising new diagnostic test for tuberculosis infection (Photo courtesy of Pexels)

Blood Test Identifies Those at High Risk of Developing Human Tuberculosis

New research presented at ECCMID 2022 has shown that Actiphage, a new blood test for Mycobacterium tuberculosis (Mtb) can improve identification of those at risk of progressive tuberculosis infection, offering potential for a rapid, non-invasive biomarker for early screening of asymptomatic individuals. More...
26 Apr 2022
Image: Blood-based assay could aid management of relapsing-remitting form of MS (Photo courtesy of Quanterix)

NfL Blood Test to Aid Prognosis and Treatment of Multiple Sclerosis

A blood-based assay has the potential to serve the multiple sclerosis (MS) community in management of relapsing-remitting form of the disease. More...
25 Apr 2022
Image: The CRC-PREVENT study will evaluate individuals at risk for colorectal cancer (Photo courtesy of Geneoscopy)

RNA-Based Noninvasive Gut Tests Enable Early Colorectal Cancer Screening

A new diagnostic platform uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. Unlike other noninvasive screening options that use DNA or blood-based biomarkers, the proprietary method from Geneoscopy Inc. (St. Louis, MO, USA) analyzes RNA extracted from patient stool samples to provide the phenotypic and quantitative information necessary to accurately detect precancerous lesions. More...
25 Apr 2022
Image: Researchers have identified a blood plasma biomarker for early-stage AD (Photo courtesy of Pexels)

Blood Plasma Biomarker May Facilitate Rapid Diagnosis of Early-Stage Alzheimer’s Disease

The discovery of a unique ratio of metabolites from blood samples of early-stage Alzheimer’s disease patients promises to speed diagnosis, allowing earlier treatments to be initiated. More...
22 Apr 2022
Image: BD Rhapsody TCR/BCR multiomic assay advances immunology research capabilities in multiomics (Photo courtesy of BD)

New BD Assay Speeds Discovery in Autoimmune Disorders, Immuno-Oncology, and Infectious Diseases

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has launched the BD Rhapsody TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases. More...
22 Apr 2022
New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Host Response Immunoassay Test
MeMed BV


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2025 Globetech Media. All rights reserved.